Frontiers in Oncology | Hematologic Malignancies

Systematic Review

Published on 21 Jan 2025

Management of CAR-T cell therapy in patients with multiple myeloma: a systematic review and expert consensus in Australia

in Hematologic Malignancies

P. Joy Ho
Hang Quach
M. Hasib Sidiqi
Cindy H. Lee
Jason Butler
Andrew Spencer
Kenneth Micklethwaite
Jingya Li
Elissa Cusson
Robert Bagnall

Frontiers in Oncology

doi 10.3389/fonc.2024.1535869

2,191 views

Original Research

Published on 21 Jan 2025

Transcription factor KLF2 is associated with the dysfunctional status of NK cells and the prognosis of pediatric B-ALL patients

in Hematologic Malignancies

Fang Wu
Huimin Xu
Benshan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1456004

1,010 views

Review

Published on 20 Jan 2025

Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia

in Hematologic Malignancies

Elissa Tjahjono
Megan R. Daneman
Bernadetta Meika
Alexey V. Revtovich
Natalia V. Kirienko

Frontiers in Oncology

doi 10.3389/fonc.2024.1532857

1,805 views

Review

Published on 16 Jan 2025

Exosomal lncRNAs as diagnostic and therapeutic targets in multiple myeloma

in Hematologic Malignancies

Hong Yan
Nan Jiang
Xiaoying Li
Chenyang Lin
Fang Wang
Juan Zhang
Lijuan Chen
Dan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1522491

1,099 views
1 citation

Original Research

Published on 07 Jan 2025

Real-world experiences with brentuximab vedotion-based regimens in systemic anaplastic large cell lymphoma: a multi-center retrospective study

in Hematologic Malignancies

Zhiqiang Zhao
Qinchuan Yu
Liping Su
Jianxia He
Jie Tao
Yanfeng Xi
Yujiao Guo
Yanhong Luo
Lieyang Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1494384

933 views

Original Research

Published on 07 Jan 2025

Investigating resistance to 5-Azacytidine and Venetoclax in PDX models of MDS/AML

in Hematologic Malignancies

Petra Bašová
Lubomír Minařík
Silvia Carina Magalhaes-Novais
Jana Balounová
Zuzana Zemanová
Tatiana Aghová
Martin Špaček
Anna Jonášová
Kristýna Gloc Pimková
Jan Procházka

Frontiers in Oncology

doi 10.3389/fonc.2024.1414950

1,429 views

Systematic Review

Published on 07 Jan 2025

The efficacy and safety of CD7 chimeric antigen receptor T-cell therapy for hematologic malignancies: a systematic review and meta-analysis

in Hematologic Malignancies

Jile Liu
Yuxin An
Rui Sun
Xiaomei Zhang
Shujing Guo
Xuejin Gao
Mingfeng Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1478888

1,451 views

Original Research

Published on 06 Jan 2025

Loss of SMAD1 in acute myeloid leukemia with KMT2A::AFF1 and KMT2A::MLLT3 fusion genes

in Hematologic Malignancies

Lisa Dietsche
Kristin Stirm
Veronika Lysenko
Corina Schneidawind
Alexandar Tzankov
Anne Müller
Alexandre P. A. Theocharides

Frontiers in Oncology

doi 10.3389/fonc.2024.1481713

1,044 views

Editorial

Published on 06 Jan 2025

Editorial: Acute leukemias: molecular characterization, leukemia-initiating cells, and influence of the microenvironment, volume II

in Hematologic Malignancies

Lokman Varisli
Garrett M. Dancik
John A. Copland
Spiros A. Vlahopoulos

Frontiers in Oncology

doi 10.3389/fonc.2024.1542306

542 views

Original Research

Published on 06 Jan 2025

Prognostic risk factors of pneumonia associated with COVID-19 in patients with lymphoma

in Hematologic Malignancies

Dan Liu
Xia Yin
Hui Wang
Lijie Xing
Ping Li
Haichen Wei
Ji Ma
Qiang He
Linna Xie
Ke Lu

Frontiers in Oncology

doi 10.3389/fonc.2024.1504809

725 views

Original Research

Published on 06 Jan 2025

Outcome of critically ill patients receiving systemic chemotherapy on the intensive care unit

in Hematologic Malignancies

Panagiotis Karagiannis
Felix Klingler
Viktor Arelin
Winfried Alsdorf
Christina König
Kevin Roedl
Walter Fiedler
Katja Weisel
Stefan Kluge
Carsten Bokemeyer

Frontiers in Oncology

doi 10.3389/fonc.2024.1508112

1,135 views

Case Report

Published on 06 Jan 2025

Case report: a 3-year follow-up on nodal marginal zone lymphoma coexisting with disseminated Talaromyces marneffei infection in a non-endemic area

in Hematologic Malignancies

Xiping Yu
Houyun Xu
Junjie Zhou
Zhiqiang Zhu
Baizhou Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1407893

555 views

Review

Published on 24 Dec 2024

BTK inhibition in primary central nervous system lymphoma: mechanisms, clinical efficacy, and future perspectives

in Hematologic Malignancies

Yurou Xing
Kejia Zhao
Yi Zhang
Yongsheng Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1463505

1,254 views

Case Report

Published on 19 Dec 2024

Selinexor in combination with venetoclax and decitabine in patients with refractory myelodysplastic syndrome previously exposed to hypomethylating agents: three case reports

in Hematologic Malignancies

Yunshuo Xiao
Kun Yang
Qiuying Huang
Changqing Wei
Manlv Wei
Zhili Geng
Hui Wu
Tianhong Zhou
Xialoin Yin
Yali Zhou

Frontiers in Oncology

doi 10.3389/fonc.2024.1477697

1,085 views

Case Report

Published on 17 Dec 2024

Obinutuzumab-induced acute thrombocytopenia: a case report and literature review

in Hematologic Malignancies

Xuelin Dou
Kongyang Li
Jin Lu

Frontiers in Oncology

doi 10.3389/fonc.2024.1509567

961 views

Clinical Trial

Published on 16 Dec 2024

A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma

in Hematologic Malignancies

Jeffrey J. Pu
Kristin N. Berger
Chunlei Zheng
Nhan Do
David F. Claxton
W. Christopher Ehmann
Joseph J. Drabick
Haiquan Li
Thomas P. Loughran
Elliot M. Epner

Frontiers in Oncology

doi 10.3389/fonc.2024.1449401

1,156 views